Storage: Keep at 2°C – 8°C at all times.

Description: Ozempitai (semaglutide) is used for type 2 diabetes in adults to improve blood sugar levels and also to lower the risk of major cardiovascular events like stroke, heart attack, or death, for adults with type 2 diabetes with heart disease. In clinical trials, Ozempitai has also been shown to help with weight loss, after 30 weeks, patients on Ozempitai 0.5mg had lost 2.6 kg more than the placebo group, and patients on Ozempitai 1mg lost 3.5 kg more than the placebo group. Although currently, Ozempic is not an FDA-approved weight loss medicine.

Ozempitai works to lower blood sugar, helping the pancreas make more insulin, decreasing the amount of sugar your liver makes, and slowing the rate food passes through your body, making you feel full longer. Ozempitai is from a class of medicines called glucagon-like peptide-1 (GLP-1) agonists that work by binding to GLP-1 receptors which results in lower blood sugar levels and A1C levels and may also reduce your appetite to help weight loss.

Ozempitai is a once-weekly injection that should be used along with diet and exercise. Ozempitai should not be used for type 1 diabetes mellitus.